Sector: Pharmaceuticals

Latest content

Counterfeit vaccines highlight dark web’s role in illicit supply chains

As nations begin the roll-out of covid-19 vaccines, there is a risk of bad actors cashing in on the unprecedented demand through dark web marketplaces.

08 January 2021

P&G's PITERA mark is famous, says Patent Court

In a victory for The Procter & Gamble Company, the Patent Court of Korea has held that the PITERA mark is famous in South Korea, independently from the SK-II brand.

08 January 2021

Rebranding opportunity and risk in the spotlight as Pfizer launches new logo

With the eyes of the world on Pfizer, WTR spoke to experts on what the pros and cons might be for undergoing a rebrand at such a pivotal moment.

07 January 2021

“The quality of the names is crucial”: Novartis’ top tips for pharma branding success

David Lossignol, head of the pharma legal brand IP team at Novartis, reveals how he managed to juggle the 2019 INTA presidency alongside increasing duties at the company, to earn his operation the WTR Healthcare and Life Sciences Team of the Year Award.

23 December 2020

Preparation and collaboration: the cornerstones of any successful brand strategy

Carnot Laboratorios general counsel Antonio Donatlán Herrera reveals how his team handled the IP intricacies of a multinational brand launch in an industry where the threat of counterfeits is a threat to human health.

22 December 2020

WTR Brand Elite hits three-year high as share values rebound strongly

The WTR Brand Elite project tracks how a defined set of brand-focused companies with industry-leading trademark teams perform against stock market indices.

17 December 2020

Double examination of trademark applications: National Trademark Office develops worrying new practice

A new practice initiated by Colombia’s National Trademark Office is causing concern in the trademark community, as second-instance decisions - which, according to the law, cannot be subject to further legal remedies - are no longer the final decisions in the administrative process.

09 December 2020

‘.io’ Policy no BETR for complainant

This case shows that, even though the bad-faith requirements of the ‘.io’ Policy are more relaxed than those of the UDRP, the standard of proof of each alleged bad-faith argument under the ‘.io’ Policy is no lower.

07 December 2020

Amazon v InfoHealth and the reality of David versus Goliath trademark cases

In late November UK media reports seized on allegations of trademark bullying on the part of Amazon. However, this guest post argues that the situation was more nuanced than reported.

03 December 2020

Get unlimited access to all WTR content